SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-022828
Filing Date
2022-05-02
Accepted
2022-04-29 18:44:15
Documents
14
Period of Report
2022-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159144-8k_180life.htm   iXBRL 8-K 34853
2 PRESS RELEASE DATED APRIL 29, 2022 ea159144ex99-1_180life.htm EX-99.1 25450
  Complete submission text file 0001213900-22-022828.txt   291964

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20220429.xsd EX-101.SCH 3798
4 XBRL DEFINITION FILE atnf-20220429_def.xml EX-101.DEF 26891
5 XBRL LABEL FILE atnf-20220429_lab.xml EX-101.LAB 36930
6 XBRL PRESENTATION FILE atnf-20220429_pre.xml EX-101.PRE 25513
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159144-8k_180life_htm.xml XML 5702
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 22878370
SIC: 2834 Pharmaceutical Preparations